Defining contrast-induced nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 7, 2009, Pages 1151-1153

  Palevsky, Paul M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CREATININE; CYSTATIN C; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; IODINATED CONTRAST MEDIUM; IODIXANOL; IOPAMIDOL; MANNITOL; NATRIURETIC FACTOR; SODIUM CHLORIDE; THEOPHYLLINE; CONTRAST MEDIUM;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIABETES MELLITUS; EDITORIAL; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MORTALITY; OUTCOME ASSESSMENT; RENAL REPLACEMENT THERAPY; RISK FACTOR; SAMPLE SIZE; VASCULAR DISEASE; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; INCIDENCE; NOTE;

CONTRAST MEDIA; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; RISK FACTORS;

EID: 70349318100     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03410509     Document Type: Editorial

References (29)

1. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002
2. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420, 1994
3. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H: Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329-336, 2002
4. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 291: 2328-2334, 2004
5. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ: Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. JAMA 300: 1038-1046, 2008
6. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F: Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52: 599-604, 2008
7. Joannidis M, Schmid M, Wiedermann CJ: Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: A meta-analysis. Wien Klin Wochenschr 120: 742-748, 2008
8. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31: 674-680, 1998
9. Weisberg LS, Kurnik PB, Kurnik BR: Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 15: 61-68, 1993
10. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 290: 2284-2291, 2003
11. Bagshaw SM, Ghali WA: Theophylline for prevention of contrast-induced nephropathy: A systematic review and meta-analysis. Arch Intern Med 165: 1087-1093, 2005
12. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC: Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148: 284-294, 2008
13. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrastagent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000
14. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL: N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354: 2773-2782, 2006
15. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL: The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349: 1333-1340, 2003
16. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Grazi M, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL: Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in highrisk patients. Am J Med 119: 155-162, 2006
17. Cruz DN, Perazella MA, Bellomo R, Corradi V, de Cal M, Kuang D, Ocampo C, Nalesso F, Ronco C: Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: A systematic review. Am J Kidney Dis 48: 361-371, 2006
18. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, Van-Fossen DB: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 47: 254-261, 1995
19. Barrett BJ, Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188: 171-178, 1993
20. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491-499, 2003
21. McCullough PA, Bertrand ME, Brinker JA, Stacul F: A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48: 692-699, 2006
22. Heinrich MC, Haberle L, Muller V, Bautz W, Uder M: Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: Meta-analysis of randomized controlled trials. Radiology 250: 68-86, 2009
23. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE: Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115: 3189-3196, 2007
24. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996
25. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103: 368-375, 1997
26. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548, 2000
27. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264, 2002
28. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, Palevsky PM: Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17: 2871-2877, 2006
29. Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ: Contrast-induced nephropathy and long-term adverse events: Cause and effect? Clin J Am Soc Nephrol 4: 1162-1169, 2009